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Costa, Mario, Silvia Barogi, Nicholas D. Socci, Debora Ange-
loni, Margherita Maffei, Barbara Baragatti, Chiara Chiellini,
Emanuela Grasso, and Flavio Coceani. Gene expression in ductus
arteriosus and aorta: comparison of birth and oxygen effects. Physiol
Genomics 25: 250–262, 2006. First published January 17, 2006;
doi:10.1152/physiolgenomics.00231.2005.—Ductus arteriosus (DA)
closure is initiated by oxygen rise postnatally and progresses in two,
functional-to-permanent, stages. Here, using GeneChip Arrays in rats
(normoxic and hyperoxic fetus, normoxic newborn), we examined
whether oxygen alone duplicates the birth process in affecting DA
genes. In addition, by comparing DA with aorta (Ao), we identified
features in postnatal gene profile marking transitional adjustments in
a closing (DA) vs. a persistent (Ao) vessel. We found changes in
neonatal DA denoting enhanced formation and action of the constric-
tor endothelin-1 (ET-1). Likewise, ANG II type 1 receptor was
upregulated, and the compound was a constrictor. Conversely, relax-
ant PGE2 became less effective. Among agents for functional closure,
only ET-1 was affected similarly by oxygen and birth. Coincidentally,
neonatal DA showed enhanced contractile drive with upregulation of
Rho-Rho kinase and calcium signaling along with downregulation of
contractile proteins. The latter effect was shared by oxygen. Changes
denoting active remodeling were also seen in neonatal but not hyper-
oxic fetal DA. Ao, unlike DA, exhibited postnatal variations in
noradrenergic, purinergic, and PGI2 systems with opposing effects on
vasomotion. Contraction and remodeling processes were also less
affected by birth, whereas lipid and glucose metabolism were upregu-
lated. We conclude that several agents, including ANG II as novel
effector, promote functional closure of DA, but only ET-1 is causally
coupled with oxygen. Oxygen has no role in processes for permanent
closure. Functional closure is associated with downregulation of
contractile apparatus, and this may render neonatal DA less amenable
to tone manipulation. Conceivably, activation of metabolism in neo-
natal Ao is a distinguishing feature for transitional adaptations in the
permanent vasculature.
ductus closure; postnatal programming; fetal and neonatal physiology
THE CARDIOVASCULAR SYSTEM undergoes major changes during
the transition from intra- to extrauterine life, and among these
closure of a shunt, the ductus arteriosus (DA) connecting the
pulmonary artery with the aorta (Ao), has received much
attention for its immediacy, impact on hemodynamics, and
feasibility of therapeutic manipulation (30). Preparation for
this event begins early in gestation with development of a
prominent muscle layer within the vessel wall, progresses with
formation of intimal cushions in species whose duct exceeds a
critical size (e.g., humans but not rodents), and culminates at
birth with an abrupt contraction and, ultimately, with structural
changes leading to obliteration (3). Several factors have been
implicated in this sequence, with the action of vasoactive
agents for the initial functional closure being intertwined with
the remodeling process for permanent closure. Specifically, at
birth there is synergism between activation of a contractile
mechanism, conceivably involving endothelin-1 (ET-1) (11,
19, 33) and a voltage-gated K (Kv) channel (19, 24) as
effectors, and removal of a tonic relaxation from blood-borne
PGE2 (11, 13). Critical for the onset of this constriction is the
postnatal rise in blood oxygen tension. Coincidentally, as the
vessel narrows, a series of structural alterations begins in
which several factors (adhesion factors, vascular endothelial
cell growth factor, fibronectin, laminin, cytokines, certain apop-
tosis-linked molecules) (7–9, 16, 20, 22, 29, 35) have already
been implicated. Changes comprise a progressive intimal
thickening secondary to endothelium ingrowth and muscle cell
migration, media remodeling through a combination of muscle
proliferation/dedifferentiation and apoptosis, and, finally, ap-
position of endothelial lining with the ensuing obliteration of
the vessel lumen. Although the essential features of this se-
quence are known, no information is available on the actual
role being played by oxygen in its individual steps. In partic-
ular, from the available data it is not clear whether oxygen
simply serves as trigger for functional DA closure or whether
certain aspects of the subsequent vessel remodeling are also
directly connected to the action of this agent. An additional,
broader question is how transitional adjustments at birth con-
dition the gene expression profile in DA vis-a`-vis a vessel, such
as Ao, that remains patent. Both issues were addressed in our
investigation. Elucidation of these points is important not only
to better characterize oxygen-linked events but also to fully
define vascular mechanisms being affected by the birth pro-
cess. In addition, knowledge of the gene profile in the perinatal
vasculature may serve as a reference for any investigation of a
developmental link in cardiovascular diseases of the adult.
Using GeneChip arrays, we confirmed the importance of
changes in the ET-1 and PGE2 systems for functional DA
closure but, at the same time, identified in ANG II a potential
additional effector. Only ET-1 function, however, was linked
with oxygen. As anticipated, DA exhibited a cohort of gene
changes denoting active remodeling. Among these, an unex-
pected feature was the downregulation of contractile proteins
appearing as a sign of oxygen action. The remainder of the
remodeling process could instead be connected causally with
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signals deriving from shear stress on the luminal surface of the
narrowing vessel and the subsequent intramural hypoxia. Con-
trary to DA but consistent with tone regulation, Ao showed
postnatal activation of vasomotor mechanisms with opposing
effects. Coincidentally, there was upregulation of genes for
energy metabolism, manifesting collectively the demands of a
rapidly growing and differentiating organ.
METHODS
Isolation of rat DA and Ao. Long-Evans rats were mated for 24 h,
and the end of this period was marked as day 0 of pregnancy.
Near-term fetuses (gestational age 19 days) were delivered by cesar-
ean section under chloral hydrate anesthesia (35–70 mg/100 g body wt
ip) from a normoxic or hyperoxic dam, whereas newborns were used
3 h after vaginal delivery. Pregnant rats were made hyperoxic to
reproduce in utero the neonatal condition with the attendant DA
constriction (11). They breathed 100% oxygen inside a box for 3 h,
and throughout this procedure they were anesthetized with chloral
hydrate and kept warm with water-filled bags at 39°C. Control
experiments confirmed that blood PO2 values for the fetuses from
hyperoxic dams were within the range of those for newborns (see
Supplemental Table 4, available at the Physiological Genomics web
site).1 All animals were killed by cervical dislocation and, to isolate
the DA and Ao (arch and thoracic sections), were secured inside a
chamber filled with ice-cold Krebs medium through which was
bubbled a gas mixture with 2.5% (fetus) or 12.5% (newborn) oxygen
(1). Special care was taken to obtain blood vessels free of any
adhering tissue.
Total RNA preparation. Specimens from normoxic (DA, Ao) and
hyperoxic (DA) fetuses and newborns (DA, Ao) were pooled to obtain
five distinct groups (n  52–142/group and 20–25/group, respec-
tively, for DA and Ao) and were homogenized in TriPure isolation
reagent (Roche, Indianapolis, IN). The procedure followed a pub-
lished protocol (1), and RNA yield was measured spectrophotometri-
cally. Quality of the material was assessed with ethidium bromide
staining on formaldehyde gel.
DNA microarray. Analysis of mRNA expression was performed
with an Affymetrix GeneChip Array (rat genome U34) comprising
three distinct gene chips for a total of 24,000 entries. Biotin-labeled
cRNA was prepared from 10 g of total RNA, as recommended by
the manufacturer. Hybridization, washing, and staining of the gene
chips were carried out in an Affymetrix oven and fluidics station.
They were then scanned with a Hewlett-Packard confocal laser scan-
ner, and images were analyzed with Affymetrix Genechip 3.3 soft-
ware. This software gave intensity data normalized against the mean
fluorescence intensity of each array. Initial analysis and pair compar-
isons were made with a twofold cutoff, a change P value of 0.0025,
and a detection P value of 0.05. After log transformation, a baseline
value of 1 was used as a reference in determining for each gene the
ratio in level of expression between newborn and fetus (1 signal log
ratio 2-fold change). Subsequent clustering of genes was performed
in two ways. In the first method (algorithm I) (37), any native
enrichment, possibly indicative of a specific function, was ascertained
in each of the four vessel-age combinations (i.e., DA/Ao vis-a`-vis
fetus/newborn) relative to the others. This was done at increasing
fold-change cutoffs (1.3, 1.6, 2, and 2.3 log ratio values) to vary the
stringency of the test. Every condition was compared with the other
three, using the standard fold-change method, and only genes that had
passed the fold-change and P-value cutoffs (see above) in all com-
parisons were added to the list. In the second mode, limited to DA
(algorithm II), overlapping changes were evidenced in the compari-
sons of the hyperoxic fetus with the normoxic newborn, using the
normoxic fetus as a reference for both. Genes were clustered into four
groups based on the sign of the two comparisons, and the attendant
coincidence, or lack of coincidence, of changes in the hyperoxic fetus
vs. the newborn (up/up, down/down, down/up, up/down) provided a
possible measure of the specific contribution of oxygen to the transi-
tional adjustments at birth. The cutoff level was, in this case, lowered
from 2 to 1.5. and the baseline value became accordingly 0.6 (0.6
signal log ratio  1.5-fold change).
The complete set of data is available in the GEO database (acces-
sion no. GSE3290).
Quantitative RT-PCR. Genes selected for this analysis (Myl2,
Agtr1a, Agtr2, Igf1, Pf4, Pparg) exemplify functional categories
relevant to our findings (see RESULTS). In addition, some of them
(Pparg, Igf1) are noteworthy for their coordinating function. DNAse I
(Roche)-treated total RNA (2 g) was reverse-transcribed with 1 U of
ThermoScript RT (Invitrogen, Carlsbad, CA) in the presence of
random hexanucleotide primers according to the manufacturer’s in-
structions. Quantitative RT-PCR (QRT-PCR) reactions (40 cycles)
were performed on an ABI Prism 7700 instrument (Applied Biosys-
tems, Foster City, CA), using TaqMan Universal PCR Master Mix
(Applied Biosystems). Primer sequences for Pparg, Igf1, Agtr1a,
Agtr2, and cyclophilin B (internal standard) were obtained from an
online library (Applied Biosystems). The remaining sequences were
designed with File-Builder software (Applied Biosystems) and were
as follows: Myl2 (exon 4): forward primer 5-ACT GTG TTC CTC
ACC ATG TTT GG, reverse primer 5-CCT TGA AGG CGT TGA
GAA TGG, probe (Fam) 5-CCG GGT CAG CTC CTT TA; Pf4
(exon 3): forward primer 5-GCC GGT CCA GGC AAA TTT TG,
reverse primer 5-CAA AGC AGG ACC CCA CTG T, probe (Fam)
5-CCC CAG CTC ATA GCC AC. Gene expression was quantified
with the comparative cycle threshold method using cyclophilin for
normalization, and results were obtained in triplicate.
Mouse DA response to ANG II. The mouse, sharing with the rat up
to 94% of the genome and the timing of DA closure (29), was used
because of the availability of reference data on vasoactive agents (1).
Near-term fetal C57BL/6 animals were delivered by cesarean section
under halothane anesthesia and were killed by cervical dislocation.
The DA was mounted in an organ bath, as previously described (1),
and mechanical tension was recorded isometrically at 2.5% or 12.5%
oxygen to mimic, respectively, the fetal or the neonatal condition.
ANG II was tested in sequential doses (0.01 nM-10 M, final in bath),
using 10-fold increments, and effects were measured by the fractional
change from baseline. Data are expressed as means  SE.
Surgical procedures and experimental protocols were approved by
the Animal Care Committee of the Ministry of Health.
RESULTS
Identification of vessel- and age-linked markers. Using al-
gorithm I (see METHODS), we found distinctive sets of genes
depending on vessel and age of the animal (DA, fetus: 4; DA,
newborn: 10; Ao, fetus: 14; Ao, newborn: 20) (Table 1). DA
showed a preferential expression of genes for contractile pro-
teins in the fetus, whereas genes for vasomotor control (Rhob,
Pde4b) and tissue remodeling (cytoskeleton/matrix compo-
nents, elements of the immune complex) became predominant
in the newborn. Quite novel among postnatal changes in DA
was the appearance of galanin (Gal), which may contribute, in
a hitherto undefined manner, to the process of closure. The
fetal Ao, on the other hand, was characterized by a diversified
transcriptional profile comprising genes for blood-borne tissue
constituents, growth (Gas2), and neurotransmission (Chgb).
No such diversification was noted in the neonatal Ao, where, in
line with the requirements of a growing organ, most marker
1 The Supplemental Material for this article (Supplemental Tables 1–4) is
available online at http://physiolgenomics.physiology.org/cgi/content/full/
00231.2005/DC1.
251GENE PROFILE IN PRENATAL VS. POSTNATAL DUCTUS AND AORTA
Physiol Genomics • VOL 25 • www.physiolgenomics.org
 o
n
 April 26, 2006 
physiolgenom
ics.physiology.org
D
ow
nloaded from
 
Table 1. Hierarchical gene clustering in DA vs. Ao before and after birth
Accession No.
(GenBank) Gene Name (UniGene)
Ratio
1.3 1.6 2.0 2.3
DA, Fetus
X07314cds_at Myosin light polypeptide 2 (Myl2) (also known as heart myosin light chain 2, MLC2)    
X15939_i_at Myosin heavy polypeptide 7, cardiac muscle,  (Myh7)    
rc_AA859372_s_at 18S ribosomal   
AF051425_at Leukocyte cell-derived chemotaxin 1 (Lect1) (also known as chondromodulin-1, Chm-1) 
X07314cds_g_at Myosin light polypeptide 2 (Myl2) (also known as heart myosin light chain 2, MLC2) 
DA, Newborn
rc_AA817956_at Transcribed locus Rn 16419    
rc_AA998352_s_at Similar to rho B (Rhob)   
rc_AI072751_at Similar to RIKEN cDNA 2610318G18  
rc_AI072166_at PDZ and LIM domain 3 (Pdlim3)  
rc_AI059824_s_at Unknown  
rc_AI058352_at Unknown  
rc_AI044631_at Similar to CD3 	-chain  
rc_AI231826_at Regulator of G protein signaling 5 (Rgs5)  
rc_AA893846_at Tenascin N (predicted) (Tnn_predicted)  
J04563_at cAMP phosphodiesterase 4B (Pde4b)  
S79711_g_at CD3 	-chain  
M18854_at T-cell receptor -chain (Tcrb) 
J03624_at Galanin (Gal) 
rc_AI070875_at Matrix Gla protein (Mgp) 
Ao, Fetus
rc_AI237884_s_at 
-Fetoprotein (Afp)    
J04215_at Integrin binding sialoprotein (Ibsp)    
X02361_at 
-Fetoprotein (Afp)    
AF019974_at Chromogranin B (Chgb)    
rc_AA875659_s_at Internexin, 
 (Inexa)   
K01231_f_at 
-Fetoprotein (Afp)  
X56327cds_s_at Hemoglobin, ε2 (Hbe2)  
M12098_s_at Embryonic sarcomeric myosin heavy chain  
rc_AA866237_s_at albumin (Alb)  
rc_AI008635_at Similar to hemoglobin: subunit   (predicted) (RGD1307486_predicted)  
rc_AI030684_at Neurofilament light polypeptide (Nfl)  
rc_AI070611_at Similar to growth arrest-specific protein 2 (Gas2)  
rc_AA860062_g_at albumin (Alb)  
X56326cds_at Hemoglobin, ε1 (predicted) (Hbe1_predicted) 
rc_AA945169_g_at Trans-thyretin (Ttr) 
rc_AA957923_at Mast cell peptidase 2 (Mcpt2) 
rc_AI227608_s_at Microtubule associated protein tau (Mapt) 
X02361_g_at 
-Fetoprotein (Afp) 
Ao, Newborn
A04674cds_s_at Uncoupling protein 1 (Ucp1)    
AB005743_g_at cd36 fatty acid transporter (Cd36)    
AF082160_at Galectin-related interfiber protein (Grifin)    
X03894_at Uncoupling protein 1 (Ucp1)    
rc_AI169612_at Fatty acid binding protein 4 (Fabp4)    
L46791_at Carboxylesterase 3 (Ces3)    
AF037072_at Carbonic anhydrase 3 (Ca3)    
rc_AI008140_at Transcribed locus Rn 122479    
rc_AI012474_at EGF-like domain 7 (Egfl7) (also known as estrogen regulator, NEU1)    
rc_AI105446_at Adipocyte complement-related protein of 30 kDa (Acdc) (also known as adiponectin)    
rc_AA819140_at Carbonic anhydrase 3 (Ca3)    
rc_AI104104_at Phosphoenol pyruvate carboxykinase 1 (Pck1)    
rc_AI232970_at Glycerol 3-phosphate dehydrogenase 1 (Gpd1)    
rc_AI176736_at Adipocyte complement-related protein of 30 kDa (Acdc) (also known as adiponectin)   
rc_AI012992_s_at Peroxisome proliferator-activated receptor, 	 (Pparg)   
J03752_at Microsomal glutathione S-transferase 1 (Mgst1)   
rc_AA799326_s_at cd36 fatty acid transporter (Cd36)  
rc_AA899681_s_at Similar to Nur77 downstream protein 2 (NDG2)  
rc_AI030436_at Fatty acid binding protein 4 (Fabp4)  
rc_AI102097_at Lipin 1 (predicted) (Lpin1_predicted)  
rc_AA946368_at cd36 fatty acid transporter (Cd36)  
rc_AA925752_at cd36 fatty acid transporter (Cd36)  
rc_AI237731_s_at Lipoprotein lipase (Lpl)  
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genes related to lipid and glucose metabolism and energy
expenditure control. Transcripts for tissue modeling and redox
state regulation made up the remainder of this pool.
Effect of oxygen vs. birth on DA gene expression. Consid-
ering that oxygen is the prime trigger for DA closure, we
investigated next whether its action on gene expression mimics
that being exerted naturally by birth. A total of 180 entries
(Supplemental Table 1) satisfied the criteria of algorithm II
(see METHODS), and among these 110 showed similar changes,
either upward (33 entries) or downward (77 entries), under the
two conditions. In those instances in which this coincidence
was missing, we found in the main downregulation by oxygen
and upregulation by birth (64 entries). The opposite relation-
ship was also seen, but it was limited to six entries.
Table 2 lists genes from this comparison identifiable with
certain functional categories. Within the structure group (group
1), genes for cell architecture, the contractile apparatus, and
blood-borne tissue constituents were, in general, similarly
affected by the two conditions. Peculiar in these events is the
reduced expression of contractile proteins in response to oxy-
gen alone, considering the role assigned to this agent in the
functional closure of the vessel. Conversely, several genes for
tissue remodeling (Tgm2, Cast), cell growth/motility (fn-1),
and cell reactivity (Cav, Thbd, Pecam1, Itga8, Emp1) were
downregulated by oxygen and upregulated by birth. The same
divergence was found in a host of genes for signaling factors
(group 2) pertaining to the viability of cells (Rgs5, Mig-6,
luc7l2), some special functions such as growth and the re-
sponse to stress (Cic, Anxa3, Mapkapk 2, Dusp 1, ankyrin
repeat and SOCS box-containing protein 2), and muscle con-
traction (Ppp1r12a, Calm1). Equally divergent were responses
of the gene for cAMP phosphodiesterase (Pde4b). Considering
the importance of Pde4b in the termination of PGE2 effects,
this finding implies that only postnatally suitable conditions
take place for curtailment of DA relaxation by PGE2 (4).
Indeed, Pde4b is a selective marker for neonatal DA (see
above). A better coincidence was noted with genes for tran-
scription factors and receptors/carriers. Specifically, Gata2,
with its potential positive control on transcription of the ET-1
gene, was upregulated in the hyperoxic fetus as in the newborn.
Similarly consistent, albeit in the opposite direction, was the
response of the ETB receptor subtype of ET-1 (Ednrb) medi-
ating vasodilatation (10). Collectively, these findings indicate
that oxygen alone may promote only one of the postulated
mechanisms (i.e., the ET-1 system) for functional closure of
DA, whereas it is unable to exert a positive effect on the host
of factors for permanent closure. Particularly significant in this
context is the downregulation of genes for vascular mechano-
transduction (Cav, Pecam1, Itga8), implying that shear stress
from oxygen constriction does not initiate any remodeling
cascade.
Genes for growth factors (group 3) were downregulated by
oxygen (Ghrh, Bmpr1a, Smoc1, Igf1 and Igf2, Fgf18) and,
with some exceptions (Ghrh, Bmpr1a), also by birth. Down-
regulation of the neuropilin gene (Nrp1) under either condition
(see group 2) is consistent with this finding. Two of three genes
for angiogenetic factors (Cyr61, Nogo, but not Crim1) behaved
in the same way, whereas the single antiangiogenesis gene
(Pf4) was consistently upregulated. On the other hand, regard-
less of their sign of action, genes for cell proliferation and
apoptosis were downregulated in the oxygen-exposed fetus and
upregulated in the newborn. The latter finding reaffirms the
concept, emerging here, that oxygen alone cannot promote the
combination of opposing, growth vs. apoptosis, processes nec-
essary for DA remodeling and, ultimately, for permanent
closure.
The metabolic system (group 4) comprised assorted genes
for cell function showing upregulation under both conditions or
downregulation with one (oxygen) and upregulation with the
other (birth). Noteworthy in the former category was the
cytochrome b5 transcript (Cyb5) for its potential facilitation of
cytochrome P-450 (CYP450)-based monooxygenase reactions.
Otherwise, a pool of genes connected with lipid and glucose
metabolism, including the transcript for a fatty acid synthase,
were uniformly downregulated. DA, in the latter respect, dif-
fers sharply from Ao.
Only few genes belonged to the immune system (group 5)
and, regardless of their action, were affected similarly by
oxygen and birth. Conversely, the MICAL 2 gene, encoding a
protein with a monooxygenase domain and possible redox-
sensitive function (34) (group 6), responded unevenly to the
two conditions.
Gene profile in DA and Ao: postnatal vs. prenatal. The
impact of birth greatly exceeds that emerging from a compar-
ison with the oxygen effect. We found a large cohort of genes
to be affected, and, despite differences between DA and Ao,
Table 1. continued
Accession No.
(GenBank) Gene Name (UniGene)
Ratio
1.3 1.6 2.0 2.3
D90109_at Acyl-CoA synthetase long chain family member 1 (Acsl1)  
rc_AA800243_at Cell death-inducing DNA fragmentation factor, alpha subunit-like effector A (predicted)
(Cidea_predicted)
 
L03294_at Lipoprotein lipase (Lpl)  
L03294_g_at Lipoprotein lipase (Lpl)  
AF072411_g_at cd36 fatty acid transporter (Cd36)  
AF072411_at cd36 fatty acid transporter (Cd36)  
M58040_at Transferrin receptor (Tfrc)  
rc_AI044900_s_at Acyl-CoA synthetase long chain family member 1 (Acsl1) 
X76453_at HRAS-like suppressor (Hrasls3) (also known as Harvey sarcoma-related suppressor) 
rc_AI045040_at Diacylglycerol O-acyl transferase homolog 2 (Dgat2) 
AB011365_s_at Peroxisome proliferator-activated receptor, 	 (Pparg) 
Gene clustering was determined in each vessel at fetal vs. neonatal age, starting from a cutoff threshold of 2-fold change (i.e., 1 signal log ratio). Selective
enrichment was recorded over a range between 2.5- and 5-fold increments (i.e., 1.3–2.3 signal log ratio values). DA, ductus arteriosus; Ao, aorta.
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Table 2. Gene expression changes in DA from hyperoxic fetus vs. newborn
Accession No. (GenBank) Gene Name (UniGene)
Ratio
F/O N
Group 1. Structural System
Membrane protein
rc_AA900440_at Similar to suppressor of Ty 3 homolog (also known as tumor endothelial marker 7, TEM7) 0.6 0.7
rc_AI235736_at CD34 0.6 0.7
rc_AI007847_s_at Similar to cytokine-induced protein 29 kDa (Homo sapiens) (CIP29) 1.4 0.6
DNA, RNA, and protein processing
D90211_s_at Lysosomal membrane glycoprotein 2 (Lamp) (also known as 96-kDa lysosomal membrane
glycoprotein, Lgp96)
0.6 0.7
rc_AI009415_f_at Cathepsin H (Ctsh) 0.8 0.7
rc_AI236150_at Similar to Down syndrome critical region 5 (predicted) (Dscr5_predicted) 0.6 0.7
rc_AA997342_at Ratsg2 (also known as selenoprotein S, VIMP) 0.7 0.6
rc_AA900283_at Similar to L41 ribosomal-like protein 1.2 0.9
rc_AA901152_g_at 18S ribosomal 1.0 1.5
rc_AA859372_s_at 18S ribosomal 0.9 3.0
rc_AA900286_g_at 45S pre 1.1 3.7
rc_AI235452_at Ribosomal protein L23a (predicted) 0.6 0.8
rc_AA946474_at Calpastatin (Cast) 0.6 0.7
rc_AI030042_at Transglutaminase 2, C polypeptide (Tgm2) 0.8 1.1
rc_AA866443_at Protease, serine 35 (Prss35) 0.7 0.7
rc_AA817968_at Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) (also known as plasma
membrane glycoprotein, PC1)
0.7 0.9
AJ010386_at CUG triplet repeat, RNA-binding protein 2 (Cugbp2) (also known as ETR-R3b protein) 1.0 0.6
X59961_at Histone 2a (RGD:621437) 0.6 0.7
AF036335_at nonO/p54nrb homolog (Sfpq) 0.6 0.6
rc_AI007953_at Similar to ribosomal protein S10 1.1 0.6
rc_AA997731_at Similar to splicing factor arginine/serine-rich 6 (SRP55-2), isoform 2 1.1 1.0
rc_AA957260_at Ribonucleotide reductase M2 (Rrm2) 1.1 0.7
rc_AA963794_at Vascular endothelial zinc finger 1 (predicted) (Vezf1_predicted) (also known as SFRS1
splicing factor)
0.9 0.8
rc_AA893870_at Similar to pre 45S 1.3 2.2
rc_AA893870_g_at Similar to pre 45S 1.6 2.1
rc_AA900974_at Similar to 28S ribosomal 2.6 2.3
Cytoskeleton and matrix components
rc_AI175875_s_at Procollagen, type IV, 
1 (predicted) (Col4a1_predicted) 0.6 0.6
rc_AI237589_at Extracellular matrix protein 1 (Ecm1) 0.6 0.9
rc_AA799497_at Similar to tensin (Tns) 0.6 1.1
U90121_at Thrombomodulin (Thbd) 0.8 1.0
U77697_at Platelet-endothelial cell adhesion molecule 1 (Pecam1) 1.0 0.8
U26310_at Tensin (Tns) 1.3 0.6
U82612cds_g_at Fibronectin 1 (fn-1) 2.5 0.8
rc_AI102830_at Fibronectin 1 (fn-1) 0.8 0.8
M28259cds_at Fibronectin gene, exon 2b and 3a (fn-1) 2.6 1.4
Z46614cds_at Caveolin (Cav) 1.3 0.7
rc_AI029942_at Caveolin (Cav) 0.7 0.9
rc_AI639291_at Integrin 
8 (Itga8) 0.7 1.0
rc_AA955964_at Olfactomedin-like 2B (predicted) (Olfml2b_predicted) 1.5 1.3
Z54212_at Epithelial membrane protein 1 (Emp1) 1.4 0.8
R46974_s_at Collagen, type III, 
1 (Col3a1) 1.3 0.6
X81449cds_at Type I keratin 19 (Krt1-19) 1.2 1.2
X81449cds_g_at Type I keratin 19 (Krt1-19) 1.0 1.5
rc_AI229785_at Type I keratin 19 (Krt1-19) 1.5 2.6
rc_AA955167_s_at Myristoylated alanine-rich protein kinase C substrate (Marcks) 1.8 0.6
rc_AI172602_s_at Myristoylated alanine-rich protein kinase C substrate (Marcks) 0.9 0.9
rc_AI230834_at Myristoylated alanine-rich protein kinase C substrate (Marcks) 0.8 0.8
rc_AI45621_s_at Myristoylated alanine-rich protein kinase C substrate (Marcks) 1.5 1.0
rc_AI045621_i_at Myristoylated alanine-rich protein kinase C substrate (Marcks) 1.0 0.7
rc_AI010104_at Moesin (Msn) 0.7 0.6
rc_AI011306_at Similar to Williams-Beuren syndrome critical region protein 21 0.6 0.8
AJ224879_at Procollagen, type II, 
1 (Col2a1) 1.4 2.0
U75920_at Microtubule-associated protein, RP/EB family, member 1 (Mapre1) (also known as APC
binding protein EB1)
0.9 0.6
Contractile apparatus
S61948 Myosin heavy chain 11 (Myh11) (also known as smooth myosin heavy chain, SM1A) 1.9 0.6
rc_AI175789_at Smooth muscle 
-actin (Acta2) 0.7 0.6
X07314cds_at Myosin light polypeptide 2 (Myl2) (also known as heart myosin light chain 2, MLC2) 1.0 3.7
X07314cds_g_at Myosin light polypeptide 2 (Myl2) (also known as heart myosin light chain 2, MLC2) 0.7 1.8
X15939_i_at Myosin, heavy polypeptide 7, cardiac muscle,  (Myh7) (also known as  cardiac myosin
heavy chain)
0.9 3.7
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Table 2. continued
Accession No. (GenBank) Gene Name (UniGene)
Ratio
F/O N
X15939_r_at Myosin, heavy polypeptide 7, cardiac muscle,  (Myh7) (also known as  cardiac myosin
heavy chain)
0.7 1.3
X80130cds_i_at Similar to actin, 
, cardiac 0.9 1.9
rc_AI179415_s_at Tropomyosin 3, 	 (Tpm3) (also known as tropomyosin isoform 6) 0.6 0.7
rc_AA891522_f_at Myosin heavy chain polypeptide 6 (Myh6) 0.9 2.0
Blood-borne constituents
rc_AI028856_at Fibrinogen-like 2 (Fgl2) 0.8 1.5
X02361_g_at 
-Fetoprotein (Afp) 1.1 1.1
rc_AA894148_s_at Similar to apolipoprotein A-IV (APOA4) 1.0 1.8
Group 2. Signaling System
Transcription factors
rc_AA899775_at GATA binding protein 2 (Gata2) 0.6 1.0
rc_AI059010_at Similar to Jun D proto-oncogene (Jund) 0.6 1.4
rc_AA891829_g_at WD40 protein Ciao1 (predicted) (Ciao1_predicted) 0.6 0.6
rc_AA998123_at Small COOH-terminal domain phosphatase 1 (predicted) (Ctdsp1_predicted) 1.1 0.6
AB012230_at Nuclear factor I/B (Nfib) 0.8 0.6
rc_AA998981_at Paternally expressed 3 (predicted) (Peg3_predicted) (also known as zinc finger protein 37,
ZF37)
2.3 0.6
rc_AI175753_at Similar to zinc finger protein 307 (predicted) (Zfp307_predicted) 0.6 0.7
rc_AA800850_at Transforming protein B lymphoma Mo-MLV insertion region 1 (Bmi1) 0.6 0.7
rc_AI072036_at Cofactor for Sp1 trascriptional activation, subunit 7 (Crsp7) 0.6 0.9
Intracellular signaling including
calcium and eicosanoids
D32209_at Acidic (leucine rich) nuclear phosphoprotein 32 family, member A (Anp32a) (also known
as leucine-rich acid nuclear protein, LANP)
0.7 0.6
M24852_at Purkinje cell protein 4 (Pcp4) (also known as neuron-specific protein, PEP-19) 0.7 1.1
rc_AI103665_at Similar to luc7-like 2 (predicted) (Luc712_predicted) 1.4 0.6
X07266cds_s_at Gene 33 polypeptide (also known as similar to mitogen-inducible gene 6 protein homolog,
Mig-6)
1.0 1.9
rc_AI146189_s_at Annexin A3 (Anxa3) 0.7 0.6
rc_AI231826_at Regulator of G protein signaling 5 (Rgs5) 1.0 1.7
rc_AI237813_at MAP kinase-activated protein kinase 2 (Mapkapk2) 0.6 0.8
U02553cds_s_at Dual-specificity phosphatase 1 (Dusp1) (also known as MAP kinase phosphatase 1) 0.9 0.9
S74351_s_at Fragment of Dusp1 1.0 0.9
U50185_g_at Protein phosphatase 1, regulatory subunit 12A (Ppp1r12a) 1.0 0.7
AA799417_at Similar to ankyrin repeat and SOCS box-containing protein 2 0.9 0.6
M25350_s_at cAMP phosphodiesterase 4B (Pde4b) 0.8 1.8
rc_AI029769_at capicua homolog (predicted) (Cic_predicted) 1.7 0.7
rc_AI171814_at Calmodulin 1 (Calm1) 2.1 1.0
rc_H31692_at Eukariotic translation initiation factor 2C (Eif2c2) (also known as GERp95) 0.6 0.6
L03382_at Phospholamban (Pln) 0.7 1.1
rc_AI007974_at Similar to triple functional domain protein (PTPRF interacting protein) 0.7 1.1
rc_AI231346_at Similar to triple functional domain protein (PTPRF interacting protein) 1.0 0.9
rc_AI008687_at Similar to Wiskott-Aldrich syndrome protein (WAS1) 1.0 0.9
rc_AI030351_at Phosphatidylinositol transfer protein, membrane associated (Pitpnm1) 0.6 0.7
Receptors and carriers
rc_AI013039_at Vacuolar proton-ATPase subunit M92 (Atp6k) 0.6 0.7
rc_AI012429_at Receptor (calcitonin) activity modifying protein 1 (Ramp1) 0.6 0.7
rc_AA819381_at Chloride intracellular channel 4 (Clic4) 0.6 0.7
rc_AI170692_at GABA receptor-associated protein like 1 0.6 0.8
rc_AI176376_s_at ATPase Na/K transporting  polypeptide (Atp1b1) 0.6 0.6
X67948_at Aquaporin 1 (Aqp1) 0.6 0.8
rc_AI009843_at Neuropilin 1 (Nrp1) 0.7 0.8
X57764_s_at ET-B endothelin receptor (Ednrb) 0.7 1.2
S65355_g_at ET-B endothelin receptor (Ednrb) 1.0 0.8
rc_AA818970_s_at ET-B endothelin receptor (Ednrb) 2.7 1.7
Group 3. Tissue Modeling System
Trophic and angiogenetic factors
rc_AI169104_at Platelet factor 4 (Pf4) 1.0 1.8
Z34004exon_g_at Growth hormone-releasing hormone (Ghrh) 0.6 0.7
rc_AI179372_at Bone morphogenetic protein (BMP) receptor, type 1a (Bmpr1a) 1.0 0.6
rc_AA964288_at Similar to cysteine-rich repeat-containing protein (Crim1) 1.0 0.8
Y12760cds_at Latent TGF- binding protein-2 (Ltbp2) 1.0 1.4
rc_AI177091_at SPARC-related modular calcium binding protein 1 (Smoc1) 1.1 0.6
E00988mRNA_s_at Insulin-like growth factor II (Igf2) 1.6 1.3
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most changes could be arranged into broad categories (Sup-
plemental Tables 2 and 3). In the case of the structural
component (Supplemental Tables 2 and 3, group 1), both DA
and Ao showed a combination of upregulatory and downregu-
latory variations in the expression of genes encoding mem-
brane proteins, protein processing systems, and a vast assort-
ment of cytoskeleton/matrix constituents. Upregulation encom-
passed cytokine-induced proteins especially in Ao, distinct
structural moieties (Des, Kb4, cell surface glycoproteins,
Olfml25), and factors regulating cell growth/motility or the
ability of cells to interact with their immediate environment.
Conversely, certain genes (Tubg, Fbn2, Marcks, Cdh1, Krt1–
19, ribosomal subunits particularly in DA) were downregu-
lated. Collectively, these findings point to a structural rear-
rangement taking place in both vessels. Indeed, in accordance
with this process was a combination of upward and downward
changes in genes regulating protein processing intracellularly
(e.g., ubiquitin complex) or matrix turnover extracellularly
Table 2. continued
Accession No. (GenBank) Gene Name (UniGene)
Ratio
F/O N
rc_AI236066_at Insulin-like growth factor I (Igf1), exon 6 1.5 1.2
rc_AI112964_at Insulin-like growth factor I (Igf1), exon 4 0.7 1.3
rc_AI137820_at Cysteine-rich peptide (Cyr61) 0.6 1.2
AB004638_at Fibroblast growth factor (Fgf18) 1.0 0.9
rc_AA944838_at Foocean (Nogo) 2.7 0.7
Regulators of cell cycle and
apoptosis
AF030091_g_at Cyclin L1 (Ccnl1) 0.6 0.8
rc_AI179988_at Ectodermal neural cortex 1 (Enc1) 0.6 1.0
rc_AI011460_at Cyclin L1 (Ccnl1) 0.6 0.8
S78284_s_at Bcl-x short, apoptosis inducer 1.2 0.6
U34963_s_at Bcl2-like1, apoptosis suppressor (Bcl2l1) (also known as BCL-X long) 0.6 0.7
rc_AI237654_at Upregulated 1,25-dihydroxyvitamin D3 (Txnip) 1.0 1.0
rc_AI009002_at Cell division cycle 25B (Cdc25B) 0.6 0.7
rc_AI171616_s_at Thymopoietin (Tmpo) (also known as LAP2) 1.0 0.6
X75207_s_at Cyclin D1 (Ccnd1) 0.6 0.9
rc_AA818982_at Thymopoietin (Tmpo) (also known as LAP2) 1.8 1.1
Group 4. Metabolic System
rc_AA945054_s_at Cytochrome b5 (Cyb5) 0.9 0.6
rc_AI010267_at Cytochrome b reductase 1 (predicted) (Cybrd1_predicted) 0.6 0.6
rc_AI236332_at Spermidine/spermine N(1)-acetyltransferase (Sat) (also known as SSAT1) 0.6 1.0
rc_AA964227_at Similar to methylenetetrahydrofolate dehydrogenase (Mthtd2) 0.6 1.2
rc_AI180442_at Farnesyl diphosphate synthetase (Fdps) 0.9 0.6
M24353_at Mannosidase 2, 
1 (Man2a1) 1.1 0.6
M24353_g_at Mannosidase 2, 
1 (Man2a1) 2.0 0.6
rc_AI045939_i_at Mannosidase 2, 
1 (Man2a1) 2.3 0.8
rc_AA852004_s_at Glutamine synthetase 1 (Glu1) 0.7 1.3
rc_AI230354_at Phosphatidic acid phosphatase 2a (Ppap2a) 0.6 0.6
rc_AI233993_s_at Similar to NADH dehydrogenase subunit 5 1.0 1.0
E07296cds_s_at 
-1,3-Mannosyl-glycoprotein 2--N acetylglucosaminyltransferase (Mgat) (also known as
N-acetylglucosamine transferase 1)
0.6 0.8
rc_AI236164_at Mannosidase 2, 
1 (Man2a1) (also known as mannosyl-oligosaccharide 1,3-1,6-

mannosidase)
0.6 0.7
X55286_g_at HMG-CoA reductase (Hmgcr) 1.1 1.1
AA944077_s_at Solute carrier family 2 (facilitated glucose transporter), member 1 (Slc2a1) (also known as
glucotransferase type 1)
0.9 0.8
AF036761_at Stearoyl-CoA desaturase 2 (Scd2) 1.5 1.0
rc_AI236145_at Hydroxysteroid (17-) dehydrogenase 7 (Hsd17b7) 0.6 0.7
X13527cds_s_at Fatty acid synthase (Fans) 1.1 0.6
Group 5. Immune Response System
rc_AA818025_g_at CD59 antigen (Cd59) 0.6 0.6
H33922_f_at RT1 class Ib, locus Aw2 (RT1-Aw2) (also known as MHC class I) 0.7 1.5
U77777_s_at Interferon-	 inducing factor (I18) 0.6 0.8
rc_AI172570_at -2 Microglobulin (B2m) 0.9 1.2
rc_AI639227_at Chitinase, acid (Chia) (also known as similar to eosinophil chemotactic cytokine) 4.3 1.0
Group 6. Oxygen Adaptation System
rc_AI059216_at Similar to flavoprotein oxidoreductase MICAL 2 (predicted) 1.2 0.6
rc_AA819316_at Similar to flavoprotein oxidoreductase MICAL 2 (predicted) 0.9 1.1
Changes in gene expression were determined at each age by comparing in a single cluster analysis, respectively, the hyperoxic with the normoxic fetus and
the normoxic newborn with the normoxic fetus. Data show coincidence, or lack of coincidence, between changes in hyperoxic fetus (F/O) vs. normoxic newborn
(N). Listing includes only genes that were upregulated or downregulated by 1.5-fold (i.e., 0.6 signal log ratio) or more in a statistically significant manner (for
details, see METHODS).
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(e.g., metalloproteinase). Some responses, however, were spe-
cific to either vessel. Of note in DA was the upregulation of the
P-selectin gene (Selp) along with genes for cell growth and
migration (Tnn, mena protein, fibulin-1, osteopontin). Poten-
tially important for the timing of DA closure was also the
upregulation of a carboxypeptidase (Cpa3), i.e., an enzyme for
breakdown of the constrictor ET-1. Conversely, some struc-
ture-related genes were downregulated postnatally (actinin,
Ugcgl1, STAB1, Phactr2). Modifications specific to Ao had
also opposing sign and comprised upregulation of structure-
linked genes (Jph2, Mtap6, Grifin) with genes for cell growth
(Ler3)/differentiation (Popdc2) and downregulation of one of
the allied genes (similar to CG3284-PA).
No such diversity was noted with genes for the contractile
apparatus because their expression varied uniformly, either
downward (DA) or upward (Ao), in the immediate neonatal
period.
Few changes in both vessels concerned blood-derived fac-
tors. After birth, hemoglobin had the expected shift from fetal
to adult variant, 
-fetoprotein (Afp) was downregulated, and a
mixed group of transcripts for carriers, complement-related
molecules, and immunoglobulins was unevenly affected. Quite
striking, however, was the upregulation in Ao of genes for the
hormone adiponectin (Acdc), promoting fatty acid and glucose
metabolism, and the protease adipsin (Adn). Both these factors
are secreted by adipocytes; however, Acdc may also be formed
elsewhere (28).
Transcription factors showed a complex pattern of transi-
tional variations, with some distinctive features (Supplemental
Tables 2 and 3, group 2). Significant was the upregulation in
DA of Gata2 favoring ET-1 function. However, another mem-
ber of the same family, Gata4, linked to cardiovascular devel-
opment and differentiation, presented an opposite change.
Characteristic of Ao was the upregulation of peroxisome pro-
liferator-activated receptor-	 (Pparg) with its expected positive
control on Acdc and a cohort of genes for lipid and glucose
metabolism (see below). Both vessels, on the other hand,
shared the upregulation of BTE binding protein (Bteb1), i.e., a
factor interfering with the expression of a CYP450 gene
(CYP1A1) of potential importance for vasoregulation.
CYP1A1 may, in fact, contribute to arachidonic acid (AA)
-hydroxylation (6). Several genes for the Kru¨ppel-like family
(Klf) of transcription factors were also found, including the
endothelium-based Klf4 (upregulated) and the muscle-based
Klf5 (downregulated), respectively, in DA and Ao. Klf4 is
activated by shear stress (14) and, together with allied genes
being similarly upregulated (Cav, VE-cadherin, Itga, Pecam1;
see above), may initiate the expected remodeling in the neo-
natal DA. Downregulation of aortic Klf5, on the other hand,
accords with the regression of this particular gene with cell
maturation (14).
A mixed group of signaling factors was also affected by
birth. Noteworthy was a set of coordinated changes in tran-
scripts for the eicosanoid system and calcium regulation. In
DA, there was upregulation of phospholipase A2 (Pla2g2a),
with its inhibitor lipocortin (Anxa1), and the AA-linked 12S-
lipoxygenase (Alox15). Among the calcium-linked events was
the upregulation in DA of a cluster of genes including the
Rho-Rho kinase signaling system for contraction (Rho
B/ROK-
 complex), Calm1 with an associated modulator
(PEP-19), and the membrane transducing factor copine. Con-
comitantly, the phospholamban gene (Pln) was downregulated.
Furthermore, genes for calcium-binding proteins were either
upregulated (calgranulin A, MRP14) or downregulated
(Vsnl1). The same dual response was seen with members of the
synaptotagmin (Syt) family of calcium-sensing proteins (up-
regulation: Syt4; downregulation: Syt1). Collectively, findings
in the neonatal DA point to a modified calcium homeostasis
together with an enhanced drive toward contraction. Signifi-
cantly, the Rho-Rho kinase system may also promote transfor-
mation of the muscle cell phenotype from synthetic to contrac-
tile (36). A comparable, albeit more limited, set of changes
occurred in Ao, where, in particular, some of the genes for
calcium signaling were undetectable. However, Ao, unlike DA,
presented an upregulated PGI2 synthase gene (Ptgis).
Both DA and, to a larger degree, Ao were endowed with
genes encoding carrier molecules and assorted receptors for
vasoactive agents, cytokines, and growth factors. Particularly
significant and novel was the differential effect of birth on
genes for vasomotor mechanisms. DA showed upregulation of
the ANG II type 1 receptor gene (Agtr1a) together with
downregulation of Ednrb, and the two changes combined
conceivably have a bearing on functional closure. Ao was, in
contrast, characterized by the lesser expression of a Agtr1a-
related receptor (Agtrl1) and by the upregulation of purinergic
(P2rx1, P2ry2) and 
1-adrenergic (Adra1d) receptors. The
gene profile for receptors to chemokines/cytokines and growth
factors combined upregulatory and downregulatory variations.
In addition, peculiar to Ao was the upregulation of a transcript
for the adipocyte water channel (Aqp7).
DA and Ao shared many genes for growth and angiogenesis
undergoing transitional changes (Supplemental Tables 2 and 3,
group 3). However, whereas growth-related genes showed a
combination of upregulation and downregulation in both ves-
sels, angiogenesis-related genes presented this dual pattern
only in Ao. Specifically, we found a cohort of gene transcripts
in both vessels favoring growth through upregulation or, con-
versely, interfering with it through a set of reciprocal changes.
In addition, there were specific genes in each vessel exerting a
positive (DA: EGF-like growth factor; Ao: Lpin1, Bmp6,
Akt1, Ctgf) or a negative (DA: Itr; Ao: Nog, VEGD) influence
on growth. A similar combination of proangiogenetic (upregu-
lation: Cyr61) and antiangiogenetic (upregulation: Pf4, throm-
bospondin; downregulation: Bai3, Angpt2) responses was seen
in the neonatal Ao. Conversely, in the DA the gene transcript
for the proangiogenetic Cyr61 was downregulated, and genes
being upregulated had an antiangiogenetic action (Pf4, throm-
bospondin). Indeed, in DA angiogenesis might be favored only
by downregulation of the antiangiogenetic gene chondromodu-
lin-1 (Chm-1). This complex pattern, conceivably reflecting
events in diverse cell populations in both vessels, attests to an
active structural rearrangement that in the case of DA underlies
the evolution/involution sequence for permanent closure but in
the case of Ao ensures the acquisition of the adult asset. A
similar reasoning applies to the host of gene changes relating to
proliferation and demise of cells (see below).
We also found in the neonatal DA and Ao alterations in
genes concerning specifically the regulation of the cell cycle
and apoptosis. Many of these were vessel specific. In the case
of DA, birth elicited opposing influences on cell proliferation,
with either action resulting from reciprocal modifications in
positively and negatively acting genes. Accordingly, the hy-
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perplastic drive derived from upregulation and downregulation
of proliferative (Cdc25B) and antiproliferative (p57Kip2, Mll5,
Tmpo, Phb, similar to SKB1 homolog) genes, respectively.
This was countered by an equivalent combination of upward
(antiproliferative: Pmf31, Myd116, Btg2, Txnip, Tieg, Enc1)
and downward (proliferative: Ccna, Cdc20, Ccnd) changes. No
such arrangement was seen with apoptosis, and changes in the
neonatal DA denoted the greater impact of proapoptotic (up-
regulation: Nfkbia, TDAG51, Stk17b, Tieg) over antiapoptotic
(upregulation: Bnip3; downregulation: DIO1) influences. The
pattern was different in Ao, with the single proliferative gene
(similar to cell cycle protein p55CDC) being downregulated
and the larger pool of antiproliferative genes showing a com-
bination of upregulatory (Cdkn1a, Hrasls3, Ccnc, Btg2, Tob1,
Gadd45, Txnip) and downregulatory (Gas2, p57Kip2, Tmpo)
changes. The apoptosis system, on the other hand, presented a
host of opposite changes involving both positively acting
(upregulation: Cidea, NDG2, Nfkbia; downregulation: Cideb)
and negatively acting (upregulation: rIAP1; downregulation:
similar to HSCO protein) genes. On balance, however, the
antiapoptotic influence conceivably prevailed, in view of the
singularly striking upregulation of the rIAP1 transcript.
A separate pool of genes, particularly prominent in Ao,
related to metabolism (Supplemental Tables 2 and 3, group 4).
Some of these, being upregulated in either (DA: Sat) or both
(glnA) vessels, are concerned with tissue growth and remod-
eling. Other genes, occurring specifically in Ao, subserve
diverse aspects of cell metabolism, and among these the
upregulation of an enzyme (Gdp1) for oxidative metabolism
was particularly striking. Also noteworthy in Ao was the
upregulation of cytochrome b5 (Cyb5), possibly facilitating
CYP450-based monooxygenase reactions. The latter finding,
together with the upregulation in the same vessel of a cytosolic
epoxide hydrolase (Ephx2) and the possible modulation of
-hydroxylation reactions by Bteb1 (see above), points to a
concerted rearrangement of fatty acid metabolism and its active
products. However, distinctive for Ao was the upregulation of
a cohort of genes controlling diverse steps in lipid metabolism.
Collectively, these changes ensure availability of free fatty
acids and their utilization by cells in an organ that is growing
and is bound to remain viable. Congruent with this arrange-
ment was the selective upregulation of Pparg and Acdc (see
above). Equally specific to Ao was the upregulation of the
uncoupling protein Ucp1 with its control on energy expendi-
ture. In fact, energy homeostasis appeared to be finely regu-
lated in Ao, because there was, concomitantly, downregulation
of a second uncoupling protein (Ucp2) and upregulation of
Cidea (see above), a proapoptotic factor inhibiting Ucp1 (21).
Metabolic steps for glucose were also activated in Ao, along
with fatty acid turnover and utilization. In contrast, genes for
cholesterol biosynthesis were downregulated in both vessels.
Genes for immune receptors and related factors were also
evident in DA and, to a lesser degree, in Ao (Supplemental
Tables 2 and 3, group 5). They were unevenly affected by
birth, but, on balance, upregulation prevailed. Equally en-
hanced were components of the complement complex (see
above), whereas certain chemotactic agents exhibited divergent
changes in DA. Conceivably, these postnatal events reflect, at
least in part, a remodeling process.
Characteristic of the two vessels were genes identifiable with
neural tissue (Supplemental Tables 2 and 3, group 6). They
belonged, in the main, to structural proteins and development-
linked factors and were variably affected by birth. Most sig-
nificant in DA was the upregulation of Gal, presenting itself as
a distinct marker (see above), whereas Ao showed downregu-
lation of genes for norepinephrine synthesis and release (Ddc,
Dbh, Chgb, STX1B). The latter finding, with the concomitant
upregulation of the 
1-adrenergic receptor (see above), implies
a rearrangement of noradrenergic innervation through the tran-
sitional period at birth.
Uniformly upregulated were genes belonging to the redox/
oxygen adaptation system (Supplemental Tables 2 and 3,
group 7). They formed in both vessels a diversified group
comprising on one hand defense or adaptive factors for the
abrupt increase in tissue oxygenation at birth (Ca3, Sod2 and 3,
Hdh, Mgst1) and on the other factors (Hspb1, Hspb1a) denot-
ing a situation of stress. Apparently incongruent was the
upregulation in DA of a Hif-related gene (Rtp801), particularly
vis-a`-vis Hif1a downregulation in Ao. However, this paradox-
ical response of DA likely results from tissue hypoxia conse-
quent to forceful constriction.
QRT-PCR validation. To validate findings with the Gene-
Chip Array analysis, we performed QRT-PCR on certain genes
exemplifying postnatal adjustments of fetal DA and Ao as well
as responses of the fetal DA to oxygen. Two of these genes
were also distinctly expressed in either DA (Myl2) or Ao
(Pparg) (see Table 1). Results coincided with the microarray
data (Fig. 1). The ANG II type 1 receptor increased its mRNA
expression in DA through transition from the fetus to the
newborn (1.7-fold), and this effect was not mimicked by
oxygen, which tended to produce a change in the opposite
direction (1.4-fold decrease) (Fig. 1A). A falling trend was also
seen in Ao when comparing the prenatal with the postnatal
condition (1.6-fold decrease) (Fig. 1A). On the other hand, the
ANG II type 2 receptor, which could not be detected by
microarray analysis, was not affected by birth in DA and
decreased slightly in Ao (1.4-fold) (Fig. 1B). Myl2 mRNA
expression abated in DA from the fetus to the newborn (8-fold)
or on exposure to oxygen (2.4-fold), whereas the reverse
occurred in Ao (4.1-fold increase) (Fig. 1C). Levels of Igf1
mRNA in the fetal DA decreased on exposure to oxygen
(1.7-fold) and, to a larger degree (3.5-fold), through birth. An
even greater fall (11-fold) from the fetal value occurred in the
neonatal Ao (Fig. 1D). In contrast, Pf4 mRNA increased at
birth 3.2- and 5-fold, respectively, in DA and Ao, and a similar
trend (1.7-fold increase) was noted in DA in response to
oxygen (Fig. 1E). Likewise, Pparg mRNA rose markedly
(21-fold) from the fetal to the neonatal Ao, whereas under the
same conditions the DA signal, which had been below detec-
tion with microarray, showed only a modest increase (2-fold)
(Fig. 1F).
DA response to ANG II. ANG II contracted the mouse DA in
a concentration-dependent fashion, starting from a threshold of
1 nM (Fig. 2A). The contraction developed quickly and, after
reaching a maximum, equally rapidly abated to the original
baseline, despite the continued presence of the substance in the
bath (Fig. 2B, top). Occasionally, the reversal was not complete
and a secondary, smaller contraction ensued (Fig. 2B, middle).
The magnitude of responses was the same at 2.5% and 12.5%
oxygen (Fig. 2A). However, at the higher oxygen concentra-
tion, the contraction was followed by a relaxation (Fig. 2B,
bottom). This relaxation, unlike the contraction, did not de-
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velop dose-dependently (Fig. 2A) and could reflect an activa-
tion of the complex ANG II type 2 receptor/nitric oxide
effector (17). The alternative possibility of a PGI2 effector
function is unlikely, because the compound is not very active
on DA (30).
DISCUSSION
DA and Ao showed several differences in their postnatal vs.
prenatal gene profile. Transcripts pertaining to vasoregulatory
mechanisms presented a distinct pattern, with DA expressing
an enhanced contractile drive through appropriate modifica-
tions in the ET-1- and PGE2-linked processes and Ao exhib-
iting instead a combination of opposing influences over tone
through the involvement of noradrenergic, purinergic, and
PGI2 systems. Accordingly, a cluster of genes for contraction,
comprising the Rho-Rho kinase system and allied calcium
signaling elements, was prominently upregulated in DA. A
novel feature was the selective, birth-related upregulation of
the ANG II type 1 receptor in DA along with the demonstration
of the constrictor effect of the agent. This finding points to a
contribution of ANG II to DA closure, a possibility considered
in the past (32) but lacking direct verification in the isolated
vessel (30). Also potentially relevant to vasomotor control was
the upregulation of genes for AA metabolism via 12S-lipoxy-
genase (DA) and CYP450-based monooxygenase (DA, Ao)
pathways. The actual role being played by 12S-lipoxygenase,
Fig. 1. Quantitative RT-PCR (QRT-PCR) on selected genes from
rat ductus arteriosus (DA) and aorta (Ao). Specimens were ob-
tained from the fetus at 19 days of gestation (F), from the newborn
at 3 h of age (N), and, in the case of DA, also from the fetus of dams
made hyperoxic for 3 h (F/O). Levels of transcripts are expressed
in arbitrary units after normalization by the cyclophilin control.
Fig. 2. Effect of ANG II on the DA from fetal mouse. A:
concentration ([ANG II]) -response curve at 2.5% vs. 12.5%
oxygen (n  4 and 5). Values are means  SE (error bars not
visible are within the size of symbol). Note that a biphasic
response, with a contraction (closed symbols) being followed
by a relaxation (open symbols), was seen only at the higher
oxygen concentration. B: representative responses to 1 M
ANG II at 2.5% (top and middle) and 12.5% (bottom) oxygen.
Application took place between arrows. Scale bars, 50 mg for
5 min (100 mg wt  0.98 mN)
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counting among its products the biologically active hepoxilins
(25, 27), remains to be ascertained. Equally undefined is the
significance of Gal in the neonatal DA, although selective
appearance of this transcript may imply the operation of a
novel neurohumoral mechanism. Outwardly incongruent with
this spectrum of changes is the downregulation in DA of genes
for contractile proteins, particularly considering that the same
genes are upregulated in Ao. A plausible explanation for this
finding is that, at 3 h after birth, DA is in a transition state
characterized by a passage from functional to permanent clo-
sure. Indeed, there were coincidentally changes in a host of
genes—structural, signaling, growth and proliferation linked,
and immune system related—that denote a remodeling process
being orchestrated or already under way. Characteristic of this
process was the concomitance of hyperplastic with proapop-
totic influences, confirming earlier data in other species includ-
ing humans (16, 20, 22, 29). A similar, albeit less prominent,
remodeling was present in Ao, with genes for proliferation and
apoptosis being in particular not as conspicuous as in DA. In
fact, as expected from an organ that is bound to remain viable,
there was in the neonatal Ao, but not in DA, a coordinated
upregulation of genes encoding a broad range of factors for
glucose and lipid metabolism. Furthermore, there was in the
same vessel upregulation of adipocyte markers as well as a
concerted adjustment of uncoupling proteins, including Ucp1,
which is conventionally identified with brown adipose tissue
(21). The significance of the latter findings remains unsettled.
However, enhanced adipocyte function in Ao may be impor-
tant for the proper development of the muscle layer (2). A fine
regulation of energy homeostasis, on the other hand, may be
part of a wider process ensuring independent thermoregulation
in the neonate. In the same vein, an adaptive value may be
assigned to the birth-related upregulation of genes in both
vessels responding to oxidative stress and serving, accordingly,
as immediate defense against the transitional rise in blood
oxygen tension.
The vessel- and age-linked expression of certain genes (see
Table 1) accords with the observed pattern of transitional
changes. Specifically, in the fetus both DA and Ao preferen-
tially presented genes encoding structural elements. After birth,
however, there was a differential enrichment, with DA express-
ing genes for vasomotor control and tissue remodeling and Ao
expressing primarily genes for metabolic functions and the
control of energy expenditure. Collectively, these data reassert
a basic dichotomy in the functional arrangement of the two
vessels through the adaptation to postnatal life.
A critical question is whether postnatal changes in the gene
expression profile of DA reflect a preset programming se-
quence being initiated by birth or rather result, at least in part,
from certain intervening stimuli. Foremost among such stimuli,
for timing and impact, would be oxygen, and this possibility
was specifically addressed in our investigation. However, in
comparing the gene pattern of the hyperoxic fetus with that of
the newborn, it turned out that some key features of the
naturally closing DA are missing in the vessel being exposed to
oxygen alone. Specifically, many genes for tissue remodeling,
whether encoding structural or signaling elements, were down-
regulated by oxygen and upregulated by birth. A similar
divergence was noted with allied genes pertaining to cell
proliferation and apoptosis. None of the growth-related genes,
on the other hand, was upregulated by oxygen. Conversely,
genes potentially conditioning the contractile function of ET-1,
through upregulation (Gata2) or downregulation (Ednrb),
showed coinciding responses in the two situations. In brief,
from these data it is reasonable to conclude that the early phase
of DA closure, being functional in character, is oxygen linked,
whereas the secondary phase, leading to permanent closure,
involves a different set of factors conceivably with their own
intrinsic programming. Recent evidence (19) implicating ET-1
in the initial component of the oxygen contraction accords with
our conclusion. However, oxygen itself, although not contrib-
uting directly to the obliteration of the vessel, causes down-
regulation of genes encoding structural components of cell
architecture and the contractile apparatus (see Table 2).
The nature of the stimulus, or stimuli, for DA remodeling
and the ensuing permanent closure needs to be settled. Al-
though the operation of a defined genetic program in the
natural history of the vessel is beyond doubt (3, 30), secondary
events being triggered by the forceful contraction at birth are
also expected. Clyman and associates (8, 16) have ascribed
importance to the local hypoxia occurring across the wall of the
closing DA. Indeed, in accord with this concept, we have found
evidence of HIF-1 upregulation in the neonatal DA, standing in
contrast with the downregulation of the same gene in the
neonatal Ao. Alternatively, or concomitantly, there may be an
impact on DA of shear stress resulting from the turbulent flow
along a narrowing lumen. Consistent with the latter possibility
is the upregulation of genes, whether structural (Itga, VE-
cadherin, Cav) or signaling (Pecam1, Klf4) in character, that
are eminently susceptible to mechanical stimuli (14, 18, 23, 26,
31). Also significant here is the reported upregulation of the
ANG II type 1 receptor on mechanical stress (38). Hence, a
synergistic process may ensue, with ANG II expressing its
action not only through vasomotion but also as a remodeling
agent (5).
Our collective findings, together with existing data, allow us
to formulate a novel and comprehensive scheme for the se-
quence of events taking place in the closing DA (Table 3). The
initial phase of functional closure sees the synergistic interac-
tion of contractile (ET-1, Kv channel, ANG II) and relaxant
Table 3. Mechanisms for postnatal closure of DA
Functional Closure Remodeling/Permanent Closure
Oxygen Dependent
1 ET-1 2 Contractile proteins
2 Kv channel
Oxygen Independent
1 ANG II 1 Mechanosensitive elements
2 PGE2 ● Structural (Itga, VE-cadherin, Cav)
● Signaling (Pecam1, Kf14)
● Receptor linked (Agtr1a)
Hypoxia Dependent
1 Hif
DA closure progresses in 2 stages, from functional to permanent, and
involves distinct mechanisms that may or may not be linked to the physiolog-
ical elevation in blood oxygen tension. Hypoxia is a secondary event, occur-
ring locally within the wall of the closing vessel. There are several other
potential contributors to the process of closure (galanin, products of cyto-
chrome P-450 and hepoxilin pathways) but their role remains to be defined (for
details, see text). ET-1, endothelin-1, Kv, voltage-gated K channel.
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(PGE2) influences being increased and decreased, respectively.
ET-1 is assigned a key role because it precedes Kv changes in
the sequence of events (19) and, unlike the other putative
effectors, is linked in its function with the postnatal rise in
oxygen tension. ANG II, on the other hand, may exert a
constrictor effect directly and through its known ability to
promote ET-1 formation. The subsequent phase of permanent
closure has no causal connection with oxygen, which, by itself,
may only downregulate the contractile apparatus. Other events
come into play to initiate the remodeling sequence, and they
are identified with the shear stress on the luminal surface of the
closing DA and with the intramural hypoxia resulting from
such constriction. Conceivably, these two processes overlap in
a mutually potentiating fashion. By extension, one can envision
the situation in utero when the DA is exposed to increased
oxygen tension. The resulting constriction may in that case
involve only ET-1 and the Kv channel. ANG II is, as expected,
not affected, and PGE2 action is, if anything, enhanced because
of the downregulation of Pde4b. Furthermore, there is no
provision for secondary permanent closure because most ele-
ments in the remodeling cascade, including its putative mech-
anosensitive trigger, are downregulated and, moreover, the
intramural hypoxia is seemingly unable to promote Hif.
Our study has conceptual and practical implications. Modi-
fications in the expression of structural DA genes under the
influence of oxygen are a novel finding with potential rele-
vance to the management of sick infants requiring PGE1 to
keep their DA patent. It may account, at least in part, for the
lesser effectiveness of the compound in reopening the duct in
the normally oxygenated vs. cyanotic infant (15). Likewise, it
may explain difficulties being encountered when PGE1 is used
over an extended period of time. These patients become pro-
gressively less responsive to treatment. This phenomenon has
been ascribed to a postnatal change in receptor function (4), but
structural alterations being induced by oxygen could be an
added factor. Indeed, the complete success of any pharmaco-
logical manipulation, including the use of cyclooxygenase
inhibitors in the prematurely born infant with persistent DA,
may be conditioned by the state of the contractile apparatus.
On the other hand, the necessity of a finely orchestrated
mechanism for DA closure, being operational postnatally but
not antenatally, may explain why permanent DA closure in
utero is an exceedingly rare event despite the frequent exposure
of the fetus to constrictor drugs (12). Finally, knowledge of the
peculiarities of the gene expression profile in the developing
Ao may provide a better insight into the impact of fetal and
perinatal events as a risk factor for vascular diseases of the
adult.
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